These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11824170)

  • 1. [Chronic bronchitis. When to use antibiotics?].
    MMW Fortschr Med; 2001 Dec; 143(51-52):51. PubMed ID: 11824170
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis.
    Milstone A; Patsimas J; Farzan D; Castaldo R; Singh H; Feurer I; Harnett J; Luke DR;
    Clin Ther; 2005 Jun; 27(6):926-39. PubMed ID: 16117993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who should receive antibiotics for exacerbations of chronic bronchitis? A plea for more outcome-based studies.
    Niederman MS
    Clin Infect Dis; 2004 Oct; 39(7):987-9. PubMed ID: 15472850
    [No Abstract]   [Full Text] [Related]  

  • 4. Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity.
    Kahn JB; Khashab M; Ambruzs M
    Curr Med Res Opin; 2007 Jan; 23(1):1-7. PubMed ID: 17261234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bioparox efficiency for recurrent bronchitis of frequently ill children with fungal and bacterial colonization of the nasopharynx].
    Malanicheva TG; Ziatdinova NV; Akhmadieva LF
    Vestn Otorinolaringol; 2010; (1):76-7. PubMed ID: 20524263
    [No Abstract]   [Full Text] [Related]  

  • 6. A multicentre surveillance study on the characteristics, bacterial aetiologies and in vitro antibiotic susceptibilities in patients with acute exacerbations of chronic bronchitis.
    Hui DS; Ip M; Ling T; Chang SC; Liao CH; Yoo CG; Kim DK; Yoon HI; Udompanich V; Mogmeud S; Muttalif R; Salleh AM; Roa C; Mendoza M; Fajardo-Ang C; Soepandi P; Isbaniah F; Burhan E; Sudarmono P; Mangunnegoro H; Liu HH
    Respirology; 2011 Apr; 16(3):532-9. PubMed ID: 21299688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
    Starakis I; Gogos CA; Bassaris H
    Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
    Querol-Ribelles JM; Molina J; Naberan K; Esteban E; Herreras A; Garcia-de-Lomas J
    Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
    Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute exacerbated chronic bronchitis. Antibiotics in comparison].
    MMW Fortschr Med; 2003 Oct; 145(40):57. PubMed ID: 14603610
    [No Abstract]   [Full Text] [Related]  

  • 11. Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis.
    Miravitlles M; Kruesmann F; Haverstock D; Perroncel R; Choudhri SH; Arvis P
    Eur Respir J; 2012 Jun; 39(6):1354-60. PubMed ID: 22034649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of a 5-day treatment with an azalide (azithromycin) in superinfections of chronic bronchitis].
    Zuck P
    Rev Pneumol Clin; 1996; 52 Suppl 2():S56-9. PubMed ID: 9033919
    [No Abstract]   [Full Text] [Related]  

  • 13. Conclusions. Role of the oral Beta-lactams in the treatment of exacerbations of chronic bronchitis: critical analysis and therapeutics recommendations.
    Blasi F; Concia E; Mazzei T; Moretti AM; Nicoletti G; Novelli A; Tempera G;
    J Chemother; 2010 Nov; 22 Suppl 1():25-8. PubMed ID: 21097390
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotic treatment for patients with acute exacerbations of chronic bronchitis.
    Pacios E; Gestoso I; Villarroel P
    Clin Microbiol Infect; 2007 Jul; 13(7):747-8. PubMed ID: 17441978
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute exacerbations of chronic bronchitis: new developments concerning microbiology and pathophysiology--impact on approaches to risk stratification and therapy.
    Sethi S; Murphy TF
    Infect Dis Clin North Am; 2004 Dec; 18(4):861-82, ix. PubMed ID: 15555829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use and misuse of antibacterial agents in chronic bronchitis].
    Brubakk O; Walstad RA
    Tidsskr Nor Laegeforen; 2003 May; 123(10):1355-6. PubMed ID: 12806677
    [No Abstract]   [Full Text] [Related]  

  • 17. Azithromycin is effective in patients with chronic bronchitis.
    Kopjar B
    J Antimicrob Chemother; 2002 Sep; 50(3):433-4; author reply 434. PubMed ID: 12205072
    [No Abstract]   [Full Text] [Related]  

  • 18. [Equally whether the child's lung or chronically inflamed bronchi. Acute bacterial infections have to be terminated fast].
    MMW Fortschr Med; 2004 Mar; 146(11):56. PubMed ID: 15152775
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute exacerbated bronchitis. New guidelines for choice of antibiotics].
    MMW Fortschr Med; 2001 Nov; 143(48):59. PubMed ID: 11770382
    [No Abstract]   [Full Text] [Related]  

  • 20. Etiology issues and problems of antibiotic resistance.
    Blasi F; Concia E; Mazzei T; Moretti AM; Nicoletti G; Novelli A; Tempera G;
    J Chemother; 2010 Nov; 22 Suppl 1():8-13. PubMed ID: 21097388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.